XORTX Therapeutics Inc. (XRTX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-27
4:29 pm
Purchase
2025-10-2313GXORTX THERAPEUTICS INC PAR
XRTX
Lincoln Alternative Strategies LLC22,899
9.900%
22,899increase
(New Position)
Filing
History
2025-05-15
3:14 pm
Sale
2025-03-3113GXORTX THERAPEUTICS INC PAR
XRTX
Armistice Capital, LLC7,121
4.990%
-6,751decrease
(-48.67%)
Filing
History
2025-02-14
5:04 pm
Purchase
2024-12-3113GXORTX THERAPEUTICS INC PAR
XRTX
Armistice Capital, LLC13,872
9.990%
7,080increase
(+104.24%)
Filing
History
2024-02-14
3:03 pm
Purchase
2023-12-3113GXORTX THERAPEUTICS INC PAR
XRTX
Armistice Capital, LLC6,792
4.990%
6,050increase
(+815.36%)
Filing
History
2023-02-14
1:48 pm
Purchase
2022-12-3113GXORTX THERAPEUTICS INC
XRTX
Armistice Capital, LLC742
9.990%
742increase
(New Position)
Filing
History